Retrospective Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Jan 14, 2018; 24(2): 266-273
Published online Jan 14, 2018. doi: 10.3748/wjg.v24.i2.266
Figure 4
Figure 4 The median overall survival of patients with a ≥ 50% serum alpha-fetoprotein level decline and those with a < 50% decline was 17. 5 mo and 10.0 mo, respectively (P = 0.003).